AR015485A1 - Una capsula oral tragable que contiene paroxetina, una forma solida de dosificacion oral tragable, una formulacion farmaceutica, una procedimiento parapreparar dicha formulacion y la utilizacion de paroxetina disuelta en un vehiculo para fabricar capsulas o formas solidas de dosificacion orales trag - Google Patents

Una capsula oral tragable que contiene paroxetina, una forma solida de dosificacion oral tragable, una formulacion farmaceutica, una procedimiento parapreparar dicha formulacion y la utilizacion de paroxetina disuelta en un vehiculo para fabricar capsulas o formas solidas de dosificacion orales trag

Info

Publication number: AR015485A1
Authority: AR; Argentina
Prior art keywords: paroxetine; formulation; solid; vehicle; dissolved
Prior art date: 1997-11-21

Application number

ARP980105880A

Other languages

English (en)

Spanish (es)

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-21

Filing date

1998-11-19

Publication date

2001-05-02

1998-11-19 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2001-05-02 Publication of AR015485A1 publication Critical patent/AR015485A1/es

Links

AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title abstract 7
AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 7
229960002296 paroxetine Drugs 0.000 title abstract 7
239000007787 solid Substances 0.000 title abstract 5
238000009472 formulation Methods 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 3
238000004519 manufacturing process Methods 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
229940100691 oral capsule Drugs 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
239000002775 capsule Substances 0.000 abstract 2
239000007909 solid dosage form Substances 0.000 abstract 2
239000011324 bead Substances 0.000 abstract 1
230000002209 hydrophobic effect Effects 0.000 abstract 1
150000002632 lipids Chemical class 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
239000012669 liquid formulation Substances 0.000 abstract 1
239000003921 oil Substances 0.000 abstract 1
239000006186 oral dosage form Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

ARP980105880A 1997-11-21 1998-11-19 Una capsula oral tragable que contiene paroxetina, una forma solida de dosificacion oral tragable, una formulacion farmaceutica, una procedimiento parapreparar dicha formulacion y la utilizacion de paroxetina disuelta en un vehiculo para fabricar capsulas o formas solidas de dosificacion orales trag AR015485A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9724544.3A GB9724544D0 (en)	1997-11-21	1997-11-21	Novel Formulation

Publications (1)

Publication Number	Publication Date
AR015485A1 true AR015485A1 (es)	2001-05-02

Family

ID=10822374

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP980105880A AR015485A1 (es)	1997-11-21	1998-11-19	Una capsula oral tragable que contiene paroxetina, una forma solida de dosificacion oral tragable, una formulacion farmaceutica, una procedimiento parapreparar dicha formulacion y la utilizacion de paroxetina disuelta en un vehiculo para fabricar capsulas o formas solidas de dosificacion orales trag

Country Status (24)

Country	Link
EP (1)	EP1033986A1 (fr)
JP (1)	JP2001523718A (fr)
KR (1)	KR20010032320A (fr)
CN (1)	CN1279608A (fr)
AP (1)	AP2000001821A0 (fr)
AR (1)	AR015485A1 (fr)
AU (1)	AU1168099A (fr)
BG (1)	BG104527A (fr)
BR (1)	BR9814220A (fr)
CO (1)	CO4970832A1 (fr)
DZ (1)	DZ2658A1 (fr)
EA (1)	EA200000552A1 (fr)
GB (1)	GB9724544D0 (fr)
HU (1)	HUP0100580A3 (fr)
IL (1)	IL136106A0 (fr)
MA (1)	MA24704A1 (fr)
NO (1)	NO20002590L (fr)
OA (1)	OA11385A (fr)
PE (1)	PE20000381A1 (fr)
PL (1)	PL340555A1 (fr)
SK (1)	SK7342000A3 (fr)
TR (1)	TR200001423T2 (fr)
WO (1)	WO1999026625A1 (fr)
ZA (1)	ZA9810637B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9810180D0 (en) *	1998-05-13	1998-07-08	Smithkline Beecham Plc	Novel formulation
ATE311883T1 (de)	1999-03-12	2005-12-15	Aesica Pharmaceuticals Ltd	Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
CA2341984A1 (fr)	1999-07-01	2001-01-11	Italfarmaco S.P.A.	Complexes de paroxetine, avec des cyclodextrines et des derives de la cyclodextrine
DE19930454A1 (de) *	1999-07-02	2001-01-04	Knoll Ag	Feste Paroxetin enthaltende Zubereitungen
US6720003B2 (en)	2001-02-16	2004-04-13	Andrx Corporation	Serotonin reuptake inhibitor formulations
ATE374602T1 (de) *	2001-12-21	2007-10-15	Supernus Pharmaceuticals Inc	Orale kapselformulierung mit verbesserter physikalischer stabilität
SE0200475D0 (sv) *	2002-02-15	2002-02-15	Ltp Lipid Technologies Provide	Oral farmaceutisk beredning
WO2006119779A2 (fr) *	2005-05-10	2006-11-16	Lifecycle Pharma A/S	Composition pharmaceutique comprenant un antagoniste de l'aldosterone
US20120322752A1 (en) *	2009-12-08	2012-12-20	Sung Kyun Lee	SOLID DISPERSIONS CONTAINING 20-O-beta-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL
GB201020032D0 (en) *	2010-11-25	2011-01-12	Sigmoid Pharma Ltd	Composition
CN103961333B (zh) *	2014-05-07	2020-02-21	浙江华海药业股份有限公司	甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996031197A1 (fr) *	1995-04-03	1996-10-10	Abbott Laboratories	Melanges homogenes de medicaments fondant a basse temperature et d'additifs, destines a une liberation lente
JP2001508460A (ja) *	1997-01-15	2001-06-26	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	パロキセチン組成物

1997
- 1997-11-21 GB GBGB9724544.3A patent/GB9724544D0/en not_active Ceased
1998
- 1998-11-18 IL IL13610698A patent/IL136106A0/xx unknown
- 1998-11-18 KR KR1020007005532A patent/KR20010032320A/ko not_active Withdrawn
- 1998-11-18 PL PL98340555A patent/PL340555A1/xx unknown
- 1998-11-18 EA EA200000552A patent/EA200000552A1/ru unknown
- 1998-11-18 EP EP98954631A patent/EP1033986A1/fr not_active Withdrawn
- 1998-11-18 BR BR9814220-8A patent/BR9814220A/pt not_active Application Discontinuation
- 1998-11-18 AP APAP/P/2000/001821A patent/AP2000001821A0/en unknown
- 1998-11-18 TR TR2000/01423T patent/TR200001423T2/xx unknown
- 1998-11-18 DZ DZ980268A patent/DZ2658A1/fr active
- 1998-11-18 HU HU0100580A patent/HUP0100580A3/hu unknown
- 1998-11-18 CN CN98811404A patent/CN1279608A/zh active Pending
- 1998-11-18 AU AU11680/99A patent/AU1168099A/en not_active Abandoned
- 1998-11-18 SK SK734-2000A patent/SK7342000A3/sk unknown
- 1998-11-18 PE PE1998001126A patent/PE20000381A1/es not_active Application Discontinuation
- 1998-11-18 WO PCT/GB1998/003471 patent/WO1999026625A1/fr not_active Ceased
- 1998-11-18 JP JP2000521827A patent/JP2001523718A/ja active Pending
- 1998-11-19 AR ARP980105880A patent/AR015485A1/es unknown
- 1998-11-19 MA MA25357A patent/MA24704A1/fr unknown
- 1998-11-20 CO CO98068459A patent/CO4970832A1/es unknown
- 1998-11-20 ZA ZA9810637A patent/ZA9810637B/xx unknown
2000
- 2000-05-19 OA OA1200000153A patent/OA11385A/en unknown
- 2000-05-19 NO NO20002590A patent/NO20002590L/no not_active Application Discontinuation
- 2000-06-13 BG BG104527A patent/BG104527A/xx unknown

Also Published As

Publication number	Publication date
CO4970832A1 (es)	2000-11-07
GB9724544D0 (en)	1998-01-21
HUP0100580A2 (hu)	2002-04-29
BG104527A (en)	2001-04-30
JP2001523718A (ja)	2001-11-27
NO20002590L (no)	2000-07-19
WO1999026625A1 (fr)	1999-06-03
KR20010032320A (ko)	2001-04-16
ZA9810637B (en)	2000-05-22
AU1168099A (en)	1999-06-15
DZ2658A1 (fr)	2003-03-22
IL136106A0 (en)	2001-05-20
CN1279608A (zh)	2001-01-10
MA24704A1 (fr)	1999-07-01
SK7342000A3 (en)	2000-12-11
EP1033986A1 (fr)	2000-09-13
BR9814220A (pt)	2001-12-26
NO20002590D0 (no)	2000-05-19
PE20000381A1 (es)	2000-05-07
OA11385A (en)	2004-01-27
TR200001423T2 (tr)	2000-10-23
PL340555A1 (en)	2001-02-12
EA200000552A1 (ru)	2000-10-30
HUP0100580A3 (en)	2002-05-28
AP2000001821A0 (en)	2000-06-30

Similar Documents

Publication	Publication Date	Title
JP7501926B2 (ja)	2024-06-18	特定の胃腸部位での制御放出の剤形
US7374779B2 (en)	2008-05-20	Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
ES2164940T3 (es)	2002-03-01	Forma de dosificacion solida bioadhesiva.
BR9916224A (pt)	2001-09-04	Forma de dosagem farmacêutica oral, processos para a manufatura de uma forma de dosagem fixa, para o tratamento e a profilaxia de distúrbios gastrintestinais e para evitar efeitos colaterias gastrintestinais, uso de uma forma de dosagem, combinação, e, embalagem tipo ampola
RU2012102772A (ru)	2013-08-10	Фармацевтическая таблетка, содержащая заполненную жидкостью капсулу
JP2023078155A (ja)	2023-06-06	剤形およびそれらの使用
ES2152966T3 (es)	2001-02-16	Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion.
KR970704464A (ko)	1997-09-06	간단한 조성 및 높은 생물 유효성을 갖는 경구 투여용의 신규 사이클로스포린 제형 및 이의 제조방법(Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them)
UY25148A1 (es)	1999-01-26	Método para producir una composición farmacéutica que comprende un análogo de ácido gama aminobutírico (gaba) y una droga antiinflamatoria no esteroide (nsaid)
ES2187822T3 (es)	2003-06-16	Comprimidos de disgregacion rapida.
CO4940409A1 (es)	2000-07-24	Tableta cubierta con pelicula para seguridad mejorada del tracto gastrointestinal superior
ES2002089T3 (es)	1993-11-16	Nuevas formulaciones farmaceuticas con liberacion programada que contienen antiflogisticos.
ECSP034826A (es)	2004-02-26	Método para fabricar una composición farmacéutica de dosis baja
ES8502333A1 (es)	1985-01-01	Un procedimiento para la preparacion de una tableta farmaceutica
AU2014243929B2 (en)	2019-01-17	Compositions for treatment of xerostomia and for tooth treatment
AR011919A1 (es)	2000-09-13	FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA
BR0210224A (pt)	2004-04-13	Formas de dosagem projetada para ser engolida diretamente e apresentada como uma formulação em comprimido ou cápsula deglutìvel, e, processo para preparação de uma forma de dosagem
BR0115989A (pt)	2004-01-13	Preparação farmacêutica na forma de uma suspensão compreendendo um ingrediente ativo instável a ácido
JPH02157220A (ja)	1990-06-18	徐放性坐剤
EA200000552A1 (ru)	2000-10-30	Готовые препаративные формы, содержащие растворенный пароксетин
AR013261A1 (es)	2000-12-13	Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
MXPA06008241A (es)	2007-03-30	Composicion dermatologica de gel suave.
ES2286998T3 (es)	2007-12-16	Formulacion estable que contiene fumagillina.
MXPA04006054A (es)	2004-09-27	Composicion farmaceutica oral para capsulas blandas que contienen vinorelbine y metodo de tratamiento.
AR033331A1 (es)	2003-12-17	Formas polimorfas de un citrato de azabiciclo [2,2,2] octan-3-amina, sus composiciones farmaceuticas, procedimiento de tratamiento y procedimiento para su produccion.